| (EUR) | May 2026 | Y/Y change |
|---|---|---|
| Revenue | 225.30M | — |
| Operating expense | — | — |
| Net income | -11.30M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NG2.F returned +105.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +60.9% |
| 1 year | +105.4% |
| 5 years | -73.5% |
| 10 years | -49.2% |
| All-time high | €40.40 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in NG2.F would be worth today ›No. Neogen Corporation has not paid a dividend in the past 12 months.
Neogen Corporation is part of the Healthcare sector.
Neogen Corporation has a market cap of 2.14B EUR, based on the latest quote.
Neogen Corporation is expected to report earnings around Oct 8, 2026. That date is an estimate and has not been confirmed by the company.
